Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related Complications.

  • 2021-06-28
  • Frontiers in immunology 12

Study Design

Type
Review

Introduction

Several months ago, Chinese authorities identified an atypical pneumonia in Wuhan city, province of Hubei (China) caused by a novel coronavirus (2019-nCoV or SARS-CoV-2). The WHO announced this new disease was to be known as "COVID-19".

Evidence acquisition

Several approaches are currently underway for the treatment of this disease, but a specific cure remains to be established.

Evidence synthesis

This review will describe how the use of selected nutraceuticals could be helpful, in addition to pharmacological therapy, in preventing some COVID-19-related complications in infected patients.

Conclusions

Even if a specific and effective cure for COVID-19 still has some way to go, selected nutraceuticals could be helpful, in addition to pharmacological therapy, in preventing some COVID-19-related complications in infected patients.

Research Insights

    Back to top